Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 273 participants.
Also called NCT02782026
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 273 participants
- Registry
-
NCT02782026
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT02782026. Non-randomized; no masking; primary purpose diagnostic. Start 2016-03-04 (actual); primary completion 2018-08-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension
- Acronym
- SNOOPY2
- Condition
- Pulmonary Hypertension
- Intervention (Device)
- Exhaled Breath Olfactory Signature (Artificial Nose)
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Collaborator
- Technion, Israel Institute of Technology
- Collaborator
- Bayer
Record details
- Record id
cardio:ct-nct02782026- Content hash
cc399ce38bf3ef2bcc9c4db5e02746efb4b29a5f4dc59546b76081365b3059a0